nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—KCNJ11—type 2 diabetes mellitus	0.32	1	CbGaD
Levosimendan—KCNJ11—Tolazamide—type 2 diabetes mellitus	0.0859	0.161	CbGbCtD
Levosimendan—KCNJ11—Glimepiride—type 2 diabetes mellitus	0.0766	0.143	CbGbCtD
Levosimendan—KCNJ11—Glipizide—type 2 diabetes mellitus	0.0701	0.131	CbGbCtD
Levosimendan—KCNJ11—Gliclazide—type 2 diabetes mellitus	0.0651	0.122	CbGbCtD
Levosimendan—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.0612	0.115	CbGbCtD
Levosimendan—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.0554	0.104	CbGbCtD
Levosimendan—KCNJ11—Tolbutamide—type 2 diabetes mellitus	0.0494	0.0924	CbGbCtD
Levosimendan—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.042	0.0786	CbGbCtD
Levosimendan—KCNJ11—Glyburide—type 2 diabetes mellitus	0.0283	0.0531	CbGbCtD
Levosimendan—PDE3A—penis—type 2 diabetes mellitus	0.0051	0.261	CbGeAlD
Levosimendan—Myocardial ischaemia—Repaglinide—type 2 diabetes mellitus	0.0015	0.0236	CcSEcCtD
Levosimendan—KCNJ8—islet of Langerhans—type 2 diabetes mellitus	0.00142	0.0728	CbGeAlD
Levosimendan—Myocardial ischaemia—Rosiglitazone—type 2 diabetes mellitus	0.00142	0.0223	CcSEcCtD
Levosimendan—TNNC1—cardiovascular system—type 2 diabetes mellitus	0.00137	0.0702	CbGeAlD
Levosimendan—TNNC1—adipose tissue—type 2 diabetes mellitus	0.00121	0.0619	CbGeAlD
Levosimendan—Myocardial ischaemia—Pioglitazone—type 2 diabetes mellitus	0.00119	0.0187	CcSEcCtD
Levosimendan—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.00116	0.0593	CbGeAlD
Levosimendan—KCNJ8—cardiovascular system—type 2 diabetes mellitus	0.00103	0.0527	CbGeAlD
Levosimendan—KCNJ8—kidney—type 2 diabetes mellitus	0.001	0.0515	CbGeAlD
Levosimendan—KCNJ8—pancreas—type 2 diabetes mellitus	0.000998	0.0512	CbGeAlD
Levosimendan—KCNJ8—cortex of kidney—type 2 diabetes mellitus	0.000979	0.0502	CbGeAlD
Levosimendan—KCNJ8—adipose tissue—type 2 diabetes mellitus	0.000906	0.0464	CbGeAlD
Levosimendan—Cardiac failure—Rosiglitazone—type 2 diabetes mellitus	0.000848	0.0133	CcSEcCtD
Levosimendan—Ventricular tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00084	0.0132	CcSEcCtD
Levosimendan—KCNJ11—cardiovascular system—type 2 diabetes mellitus	0.000837	0.0429	CbGeAlD
Levosimendan—PDE3A—cardiovascular system—type 2 diabetes mellitus	0.00082	0.042	CbGeAlD
Levosimendan—KCNJ11—pancreas—type 2 diabetes mellitus	0.000813	0.0417	CbGeAlD
Levosimendan—PDE3A—adipose tissue—type 2 diabetes mellitus	0.000723	0.0371	CbGeAlD
Levosimendan—Cardiac failure—Pioglitazone—type 2 diabetes mellitus	0.000711	0.0112	CcSEcCtD
Levosimendan—Ventricular fibrillation—Losartan—type 2 diabetes mellitus	0.000669	0.0105	CcSEcCtD
Levosimendan—Angiopathy—Acarbose—type 2 diabetes mellitus	0.000658	0.0103	CcSEcCtD
Levosimendan—Malnutrition—Linagliptin—type 2 diabetes mellitus	0.000651	0.0102	CcSEcCtD
Levosimendan—KCNJ8—liver—type 2 diabetes mellitus	0.000635	0.0326	CbGeAlD
Levosimendan—Malnutrition—Nateglinide—type 2 diabetes mellitus	0.000609	0.00956	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.000566	0.00889	CcSEcCtD
Levosimendan—Cardiac disorder—Repaglinide—type 2 diabetes mellitus	0.000562	0.00883	CcSEcCtD
Levosimendan—Constipation—Miglitol—type 2 diabetes mellitus	0.000561	0.00881	CcSEcCtD
Levosimendan—Myocardial ischaemia—Ramipril—type 2 diabetes mellitus	0.000547	0.00858	CcSEcCtD
Levosimendan—Cardiac disorder—Rosiglitazone—type 2 diabetes mellitus	0.000531	0.00834	CcSEcCtD
Levosimendan—Malnutrition—Repaglinide—type 2 diabetes mellitus	0.000527	0.00828	CcSEcCtD
Levosimendan—Cardiac failure—Gliclazide—type 2 diabetes mellitus	0.000513	0.00805	CcSEcCtD
Levosimendan—Ventricular tachycardia—Losartan—type 2 diabetes mellitus	0.000512	0.00805	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.000509	0.008	CcSEcCtD
Levosimendan—PDE3A—liver—type 2 diabetes mellitus	0.000507	0.026	CbGeAlD
Levosimendan—Malnutrition—Rosiglitazone—type 2 diabetes mellitus	0.000498	0.00782	CcSEcCtD
Levosimendan—Atrial fibrillation—Valsartan—type 2 diabetes mellitus	0.000485	0.00762	CcSEcCtD
Levosimendan—Cardiac failure—Valsartan—type 2 diabetes mellitus	0.000471	0.0074	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.000463	0.00727	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.000463	0.00727	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.000458	0.0072	CcSEcCtD
Levosimendan—Constipation—Linagliptin—type 2 diabetes mellitus	0.000454	0.00713	CcSEcCtD
Levosimendan—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000449	0.00705	CcSEcCtD
Levosimendan—Cardiac disorder—Pioglitazone—type 2 diabetes mellitus	0.000445	0.007	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.000445	0.00699	CcSEcCtD
Levosimendan—Constipation—Acarbose—type 2 diabetes mellitus	0.000441	0.00692	CcSEcCtD
Levosimendan—Cardiac disorder—Sitagliptin—type 2 diabetes mellitus	0.000433	0.00679	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.000429	0.00674	CcSEcCtD
Levosimendan—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.000423	0.00664	CcSEcCtD
Levosimendan—Malnutrition—Pioglitazone—type 2 diabetes mellitus	0.000418	0.00656	CcSEcCtD
Levosimendan—Hypokalaemia—Orlistat—type 2 diabetes mellitus	0.000414	0.00649	CcSEcCtD
Levosimendan—Mental disorder—Sitagliptin—type 2 diabetes mellitus	0.000408	0.00641	CcSEcCtD
Levosimendan—Malnutrition—Glimepiride—type 2 diabetes mellitus	0.000407	0.00639	CcSEcCtD
Levosimendan—Malnutrition—Sitagliptin—type 2 diabetes mellitus	0.000406	0.00637	CcSEcCtD
Levosimendan—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000399	0.00626	CcSEcCtD
Levosimendan—Atrial fibrillation—Losartan—type 2 diabetes mellitus	0.000392	0.00616	CcSEcCtD
Levosimendan—Cardiac disorder—Bromocriptine—type 2 diabetes mellitus	0.000391	0.00615	CcSEcCtD
Levosimendan—Nausea—Miglitol—type 2 diabetes mellitus	0.00039	0.00612	CcSEcCtD
Levosimendan—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.000383	0.00601	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000371	0.00583	CcSEcCtD
Levosimendan—Mental disorder—Bromocriptine—type 2 diabetes mellitus	0.00037	0.0058	CcSEcCtD
Levosimendan—Headache—Tolbutamide—type 2 diabetes mellitus	0.000369	0.0058	CcSEcCtD
Levosimendan—Constipation—Repaglinide—type 2 diabetes mellitus	0.000368	0.00578	CcSEcCtD
Levosimendan—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000367	0.00576	CcSEcCtD
Levosimendan—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000363	0.00571	CcSEcCtD
Levosimendan—Hypokalaemia—Irbesartan—type 2 diabetes mellitus	0.00036	0.00565	CcSEcCtD
Levosimendan—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000355	0.00557	CcSEcCtD
Levosimendan—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000355	0.00557	CcSEcCtD
Levosimendan—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000353	0.00554	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000351	0.00551	CcSEcCtD
Levosimendan—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00035	0.0055	CcSEcCtD
Levosimendan—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000348	0.00546	CcSEcCtD
Levosimendan—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000341	0.00536	CcSEcCtD
Levosimendan—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00034	0.00534	CcSEcCtD
Levosimendan—Atrial fibrillation—Ramipril—type 2 diabetes mellitus	0.000337	0.00528	CcSEcCtD
Levosimendan—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000336	0.00528	CcSEcCtD
Levosimendan—Headache—Tolazamide—type 2 diabetes mellitus	0.000336	0.00528	CcSEcCtD
Levosimendan—Malnutrition—Glyburide—type 2 diabetes mellitus	0.000336	0.00527	CcSEcCtD
Levosimendan—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000334	0.00525	CcSEcCtD
Levosimendan—Headache—Linagliptin—type 2 diabetes mellitus	0.000333	0.00522	CcSEcCtD
Levosimendan—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000329	0.00516	CcSEcCtD
Levosimendan—Vomiting—Acarbose—type 2 diabetes mellitus	0.000328	0.00515	CcSEcCtD
Levosimendan—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.000327	0.00513	CcSEcCtD
Levosimendan—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000325	0.0051	CcSEcCtD
Levosimendan—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000324	0.00509	CcSEcCtD
Levosimendan—Insomnia—Glipizide—type 2 diabetes mellitus	0.000322	0.00506	CcSEcCtD
Levosimendan—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000319	0.005	CcSEcCtD
Levosimendan—Nausea—Tolazamide—type 2 diabetes mellitus	0.000319	0.005	CcSEcCtD
Levosimendan—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000316	0.00496	CcSEcCtD
Levosimendan—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00031	0.00487	CcSEcCtD
Levosimendan—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000308	0.00484	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000307	0.00483	CcSEcCtD
Levosimendan—Nausea—Acarbose—type 2 diabetes mellitus	0.000306	0.00481	CcSEcCtD
Levosimendan—Constipation—Glipizide—type 2 diabetes mellitus	0.000304	0.00478	CcSEcCtD
Levosimendan—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000303	0.00476	CcSEcCtD
Levosimendan—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000301	0.00473	CcSEcCtD
Levosimendan—Insomnia—Glimepiride—type 2 diabetes mellitus	0.0003	0.00472	CcSEcCtD
Levosimendan—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.0003	0.0047	CcSEcCtD
Levosimendan—Nausea—Nateglinide—type 2 diabetes mellitus	0.000295	0.00464	CcSEcCtD
Levosimendan—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000295	0.00464	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000294	0.00462	CcSEcCtD
Levosimendan—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000294	0.00462	CcSEcCtD
Levosimendan—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000294	0.00461	CcSEcCtD
Levosimendan—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000292	0.00459	CcSEcCtD
Levosimendan—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000289	0.00453	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000287	0.0045	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000286	0.00449	CcSEcCtD
Levosimendan—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000283	0.00445	CcSEcCtD
Levosimendan—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00028	0.0044	CcSEcCtD
Levosimendan—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000279	0.00438	CcSEcCtD
Levosimendan—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000278	0.00437	CcSEcCtD
Levosimendan—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000277	0.00435	CcSEcCtD
Levosimendan—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000275	0.00432	CcSEcCtD
Levosimendan—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000274	0.0043	CcSEcCtD
Levosimendan—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000274	0.0043	CcSEcCtD
Levosimendan—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000271	0.00426	CcSEcCtD
Levosimendan—Headache—Repaglinide—type 2 diabetes mellitus	0.00027	0.00423	CcSEcCtD
Levosimendan—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00422	CcSEcCtD
Levosimendan—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000269	0.00422	CcSEcCtD
Levosimendan—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000269	0.00422	CcSEcCtD
Levosimendan—Angiopathy—Metformin—type 2 diabetes mellitus	0.000263	0.00413	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00406	CcSEcCtD
Levosimendan—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00402	CcSEcCtD
Levosimendan—Hypotension—Glyburide—type 2 diabetes mellitus	0.000256	0.00402	CcSEcCtD
Levosimendan—Nausea—Repaglinide—type 2 diabetes mellitus	0.000256	0.00401	CcSEcCtD
Levosimendan—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000255	0.004	CcSEcCtD
Levosimendan—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000254	0.00398	CcSEcCtD
Levosimendan—Malnutrition—Metformin—type 2 diabetes mellitus	0.000252	0.00396	CcSEcCtD
Levosimendan—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000248	0.00389	CcSEcCtD
Levosimendan—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000244	0.00382	CcSEcCtD
Levosimendan—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000242	0.00379	CcSEcCtD
Levosimendan—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000241	0.00379	CcSEcCtD
Levosimendan—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00024	0.00377	CcSEcCtD
Levosimendan—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000238	0.00374	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000237	0.00371	CcSEcCtD
Levosimendan—Dizziness—Glipizide—type 2 diabetes mellitus	0.000235	0.0037	CcSEcCtD
Levosimendan—Angiopathy—Losartan—type 2 diabetes mellitus	0.000233	0.00367	CcSEcCtD
Levosimendan—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000233	0.00366	CcSEcCtD
Levosimendan—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00023	0.00361	CcSEcCtD
Levosimendan—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000227	0.00357	CcSEcCtD
Levosimendan—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00356	CcSEcCtD
Levosimendan—Vomiting—Glipizide—type 2 diabetes mellitus	0.000226	0.00355	CcSEcCtD
Levosimendan—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000226	0.00354	CcSEcCtD
Levosimendan—Headache—Glipizide—type 2 diabetes mellitus	0.000223	0.0035	CcSEcCtD
Levosimendan—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000222	0.00349	CcSEcCtD
Levosimendan—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000222	0.00348	CcSEcCtD
Levosimendan—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00022	0.00345	CcSEcCtD
Levosimendan—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000219	0.00344	CcSEcCtD
Levosimendan—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00344	CcSEcCtD
Levosimendan—Headache—Pioglitazone—type 2 diabetes mellitus	0.000214	0.00335	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000212	0.00333	CcSEcCtD
Levosimendan—Nausea—Glipizide—type 2 diabetes mellitus	0.000211	0.00332	CcSEcCtD
Levosimendan—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000211	0.00332	CcSEcCtD
Levosimendan—Hypotension—Valsartan—type 2 diabetes mellitus	0.000211	0.00332	CcSEcCtD
Levosimendan—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00331	CcSEcCtD
Levosimendan—Constipation—Gliclazide—type 2 diabetes mellitus	0.00021	0.0033	CcSEcCtD
Levosimendan—Headache—Glimepiride—type 2 diabetes mellitus	0.000208	0.00327	CcSEcCtD
Levosimendan—Headache—Sitagliptin—type 2 diabetes mellitus	0.000207	0.00326	CcSEcCtD
Levosimendan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00322	CcSEcCtD
Levosimendan—Insomnia—Valsartan—type 2 diabetes mellitus	0.000204	0.00321	CcSEcCtD
Levosimendan—Insomnia—Orlistat—type 2 diabetes mellitus	0.000202	0.00317	CcSEcCtD
Levosimendan—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000202	0.00317	CcSEcCtD
Levosimendan—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00311	CcSEcCtD
Levosimendan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000197	0.0031	CcSEcCtD
Levosimendan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00309	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000195	0.00306	CcSEcCtD
Levosimendan—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000193	0.00303	CcSEcCtD
Levosimendan—Constipation—Valsartan—type 2 diabetes mellitus	0.000193	0.00303	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000193	0.00303	CcSEcCtD
Levosimendan—Hypotension—Metformin—type 2 diabetes mellitus	0.000192	0.00302	CcSEcCtD
Levosimendan—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000192	0.00302	CcSEcCtD
Levosimendan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00299	CcSEcCtD
Levosimendan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00019	0.00299	CcSEcCtD
Levosimendan—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00019	0.00298	CcSEcCtD
Levosimendan—Headache—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00295	CcSEcCtD
Levosimendan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000187	0.00294	CcSEcCtD
Levosimendan—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000181	0.00285	CcSEcCtD
Levosimendan—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000179	0.00281	CcSEcCtD
Levosimendan—Tachycardia—Losartan—type 2 diabetes mellitus	0.000178	0.0028	CcSEcCtD
Levosimendan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000178	0.0028	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000178	0.00279	CcSEcCtD
Levosimendan—Constipation—Metformin—type 2 diabetes mellitus	0.000176	0.00276	CcSEcCtD
Levosimendan—Vomiting—Glyburide—type 2 diabetes mellitus	0.000174	0.00274	CcSEcCtD
Levosimendan—Headache—Glyburide—type 2 diabetes mellitus	0.000172	0.0027	CcSEcCtD
Levosimendan—Hypotension—Losartan—type 2 diabetes mellitus	0.000171	0.00268	CcSEcCtD
Levosimendan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000168	0.00264	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000168	0.00263	CcSEcCtD
Levosimendan—Constipation—Irbesartan—type 2 diabetes mellitus	0.000166	0.00261	CcSEcCtD
Levosimendan—Insomnia—Losartan—type 2 diabetes mellitus	0.000165	0.0026	CcSEcCtD
Levosimendan—Nausea—Glyburide—type 2 diabetes mellitus	0.000163	0.00256	CcSEcCtD
Levosimendan—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000163	0.00255	CcSEcCtD
Levosimendan—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000156	0.00246	CcSEcCtD
Levosimendan—Constipation—Losartan—type 2 diabetes mellitus	0.000156	0.00245	CcSEcCtD
Levosimendan—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000155	0.00243	CcSEcCtD
Levosimendan—Headache—Gliclazide—type 2 diabetes mellitus	0.000154	0.00242	CcSEcCtD
Levosimendan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000154	0.00241	CcSEcCtD
Levosimendan—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000153	0.0024	CcSEcCtD
Levosimendan—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000153	0.0024	CcSEcCtD
Levosimendan—Dizziness—Valsartan—type 2 diabetes mellitus	0.000149	0.00235	CcSEcCtD
Levosimendan—Dizziness—Orlistat—type 2 diabetes mellitus	0.000148	0.00232	CcSEcCtD
Levosimendan—Hypotension—Ramipril—type 2 diabetes mellitus	0.000146	0.0023	CcSEcCtD
Levosimendan—Nausea—Gliclazide—type 2 diabetes mellitus	0.000146	0.00229	CcSEcCtD
Levosimendan—Vomiting—Valsartan—type 2 diabetes mellitus	0.000144	0.00226	CcSEcCtD
Levosimendan—Vomiting—Orlistat—type 2 diabetes mellitus	0.000142	0.00223	CcSEcCtD
Levosimendan—Insomnia—Ramipril—type 2 diabetes mellitus	0.000142	0.00223	CcSEcCtD
Levosimendan—Headache—Valsartan—type 2 diabetes mellitus	0.000142	0.00222	CcSEcCtD
Levosimendan—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000141	0.00221	CcSEcCtD
Levosimendan—Headache—Orlistat—type 2 diabetes mellitus	0.00014	0.0022	CcSEcCtD
Levosimendan—Dizziness—Metformin—type 2 diabetes mellitus	0.000136	0.00214	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.00212	CcSEcCtD
Levosimendan—Nausea—Valsartan—type 2 diabetes mellitus	0.000134	0.00211	CcSEcCtD
Levosimendan—Constipation—Ramipril—type 2 diabetes mellitus	0.000134	0.0021	CcSEcCtD
Levosimendan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000133	0.00209	CcSEcCtD
Levosimendan—Nausea—Orlistat—type 2 diabetes mellitus	0.000133	0.00208	CcSEcCtD
Levosimendan—Vomiting—Metformin—type 2 diabetes mellitus	0.000131	0.00205	CcSEcCtD
Levosimendan—Headache—Metformin—type 2 diabetes mellitus	0.000129	0.00202	CcSEcCtD
Levosimendan—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000128	0.00202	CcSEcCtD
Levosimendan—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000125	0.00196	CcSEcCtD
Levosimendan—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000123	0.00194	CcSEcCtD
Levosimendan—Nausea—Metformin—type 2 diabetes mellitus	0.000122	0.00192	CcSEcCtD
Levosimendan—Headache—Irbesartan—type 2 diabetes mellitus	0.000122	0.00191	CcSEcCtD
Levosimendan—Dizziness—Losartan—type 2 diabetes mellitus	0.000121	0.0019	CcSEcCtD
Levosimendan—Vomiting—Losartan—type 2 diabetes mellitus	0.000116	0.00182	CcSEcCtD
Levosimendan—Nausea—Irbesartan—type 2 diabetes mellitus	0.000115	0.00181	CcSEcCtD
Levosimendan—Headache—Losartan—type 2 diabetes mellitus	0.000115	0.0018	CcSEcCtD
Levosimendan—Nausea—Losartan—type 2 diabetes mellitus	0.000109	0.0017	CcSEcCtD
Levosimendan—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000107	0.00168	CcSEcCtD
Levosimendan—Dizziness—Ramipril—type 2 diabetes mellitus	0.000104	0.00163	CcSEcCtD
Levosimendan—Vomiting—Ramipril—type 2 diabetes mellitus	9.97e-05	0.00156	CcSEcCtD
Levosimendan—Headache—Ramipril—type 2 diabetes mellitus	9.82e-05	0.00154	CcSEcCtD
Levosimendan—Nausea—Ramipril—type 2 diabetes mellitus	9.31e-05	0.00146	CcSEcCtD
Levosimendan—PDE3A—Signaling Pathways—VPS26A—type 2 diabetes mellitus	5.02e-05	0.000804	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.9e-05	0.000784	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MC4R—type 2 diabetes mellitus	4.89e-05	0.000782	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GIP—type 2 diabetes mellitus	4.7e-05	0.000752	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGDS—type 2 diabetes mellitus	4.66e-05	0.000745	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AANAT—type 2 diabetes mellitus	4.66e-05	0.000745	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ADRA2A—type 2 diabetes mellitus	4.56e-05	0.00073	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—ADCY5—type 2 diabetes mellitus	4.56e-05	0.00073	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TIMP1—type 2 diabetes mellitus	4.55e-05	0.000727	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAT—type 2 diabetes mellitus	4.55e-05	0.000727	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPD2—type 2 diabetes mellitus	4.42e-05	0.000707	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CDO1—type 2 diabetes mellitus	4.42e-05	0.000707	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	4.4e-05	0.000705	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS1—type 2 diabetes mellitus	4.27e-05	0.000684	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	4.25e-05	0.00068	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AK1—type 2 diabetes mellitus	4.21e-05	0.000674	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PTPN1—type 2 diabetes mellitus	4.16e-05	0.000665	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RASGRP1—type 2 diabetes mellitus	4.09e-05	0.000654	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	4e-05	0.00064	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	3.97e-05	0.000636	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CALM1—type 2 diabetes mellitus	3.92e-05	0.000627	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	3.89e-05	0.000622	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC5A4—type 2 diabetes mellitus	3.89e-05	0.000622	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MAT1A—type 2 diabetes mellitus	3.89e-05	0.000622	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	3.86e-05	0.000618	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	3.79e-05	0.000606	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENPP1—type 2 diabetes mellitus	3.75e-05	0.000601	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.75e-05	0.000601	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—G6PC—type 2 diabetes mellitus	3.75e-05	0.000601	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ND1—type 2 diabetes mellitus	3.75e-05	0.000601	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HBA2—type 2 diabetes mellitus	3.75e-05	0.000601	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	3.73e-05	0.000597	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SOD1—type 2 diabetes mellitus	3.71e-05	0.000593	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—PRKCB—type 2 diabetes mellitus	3.68e-05	0.000589	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCGR—type 2 diabetes mellitus	3.64e-05	0.000582	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GNB3—type 2 diabetes mellitus	3.58e-05	0.000573	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	3.53e-05	0.000565	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF2—type 2 diabetes mellitus	3.52e-05	0.000563	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	3.44e-05	0.000551	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—OXCT1—type 2 diabetes mellitus	3.43e-05	0.000549	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYTB—type 2 diabetes mellitus	3.43e-05	0.000549	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GCGR—type 2 diabetes mellitus	3.43e-05	0.000549	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—APOB—type 2 diabetes mellitus	3.42e-05	0.000547	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	3.39e-05	0.000542	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	3.36e-05	0.000537	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SRD5A1—type 2 diabetes mellitus	3.35e-05	0.000535	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	3.28e-05	0.000525	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	3.26e-05	0.000521	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—STAR—type 2 diabetes mellitus	3.19e-05	0.000511	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACACA—type 2 diabetes mellitus	3.19e-05	0.000511	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD17B3—type 2 diabetes mellitus	3.19e-05	0.000511	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GIPR—type 2 diabetes mellitus	3.16e-05	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRK5—type 2 diabetes mellitus	3.16e-05	0.000505	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	3.12e-05	0.000499	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CD36—type 2 diabetes mellitus	3.1e-05	0.000496	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCC8—type 2 diabetes mellitus	3.06e-05	0.00049	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CBS—type 2 diabetes mellitus	3.06e-05	0.00049	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PPP2CA—type 2 diabetes mellitus	3.06e-05	0.00049	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IAPP—type 2 diabetes mellitus	3.05e-05	0.000488	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	3.03e-05	0.000485	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	2.98e-05	0.000476	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	2.96e-05	0.000474	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	2.95e-05	0.000472	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—COX2—type 2 diabetes mellitus	2.95e-05	0.000471	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC5A2—type 2 diabetes mellitus	2.95e-05	0.000471	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA6—type 2 diabetes mellitus	2.89e-05	0.000463	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.89e-05	0.000462	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	2.88e-05	0.000462	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	2.87e-05	0.00046	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD11B1—type 2 diabetes mellitus	2.85e-05	0.000455	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—UCP2—type 2 diabetes mellitus	2.85e-05	0.000455	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—UCP3—type 2 diabetes mellitus	2.85e-05	0.000455	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	2.84e-05	0.000454	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	2.83e-05	0.000454	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MMP1—type 2 diabetes mellitus	2.83e-05	0.000452	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GIP—type 2 diabetes mellitus	2.78e-05	0.000444	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.75e-05	0.00044	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CALM1—type 2 diabetes mellitus	2.74e-05	0.000439	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—APOA1—type 2 diabetes mellitus	2.7e-05	0.000432	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.68e-05	0.000428	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PCK1—type 2 diabetes mellitus	2.68e-05	0.000428	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.64e-05	0.000422	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.63e-05	0.00042	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.62e-05	0.000419	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.61e-05	0.000417	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.58e-05	0.000414	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PRKCB—type 2 diabetes mellitus	2.58e-05	0.000413	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.58e-05	0.000412	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—type 2 diabetes mellitus	2.55e-05	0.000408	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.52e-05	0.000404	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HK1—type 2 diabetes mellitus	2.51e-05	0.000401	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.45e-05	0.000393	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD3B2—type 2 diabetes mellitus	2.42e-05	0.000387	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCKR—type 2 diabetes mellitus	2.42e-05	0.000387	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LPA—type 2 diabetes mellitus	2.42e-05	0.000387	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.39e-05	0.000382	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.36e-05	0.000378	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.35e-05	0.000376	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDOB—type 2 diabetes mellitus	2.32e-05	0.000371	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.28e-05	0.000365	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.26e-05	0.000362	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—type 2 diabetes mellitus	2.26e-05	0.000362	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT2—type 2 diabetes mellitus	2.26e-05	0.000361	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	2.23e-05	0.000357	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GLP1R—type 2 diabetes mellitus	2.16e-05	0.000345	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE1—type 2 diabetes mellitus	2.15e-05	0.000343	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—type 2 diabetes mellitus	2.14e-05	0.000343	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.12e-05	0.00034	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.11e-05	0.000337	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.09e-05	0.000334	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.09e-05	0.000334	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.06e-05	0.000329	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—type 2 diabetes mellitus	2.05e-05	0.000328	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3R1—type 2 diabetes mellitus	2.05e-05	0.000328	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.03e-05	0.000325	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.03e-05	0.000325	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.03e-05	0.000325	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.03e-05	0.000325	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.02e-05	0.000323	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC2A2—type 2 diabetes mellitus	2.01e-05	0.000322	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2e-05	0.00032	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CPT1A—type 2 diabetes mellitus	1.97e-05	0.000316	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTR—type 2 diabetes mellitus	1.97e-05	0.000316	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NAMPT—type 2 diabetes mellitus	1.93e-05	0.000309	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.93e-05	0.000309	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LIPC—type 2 diabetes mellitus	1.92e-05	0.000308	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HBA1—type 2 diabetes mellitus	1.92e-05	0.000308	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCK—type 2 diabetes mellitus	1.92e-05	0.000308	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP11A1—type 2 diabetes mellitus	1.91e-05	0.000306	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.9e-05	0.000304	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC9A1—type 2 diabetes mellitus	1.88e-05	0.0003	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.86e-05	0.000297	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CETP—type 2 diabetes mellitus	1.85e-05	0.000297	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.83e-05	0.000293	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.81e-05	0.00029	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.8e-05	0.000288	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INSR—type 2 diabetes mellitus	1.79e-05	0.000286	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.76e-05	0.000282	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.76e-05	0.000281	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.76e-05	0.000281	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.75e-05	0.00028	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.72e-05	0.000276	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SREBF1—type 2 diabetes mellitus	1.72e-05	0.000276	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SNAP25—type 2 diabetes mellitus	1.72e-05	0.000276	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PSMD6—type 2 diabetes mellitus	1.72e-05	0.000276	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CTGF—type 2 diabetes mellitus	1.69e-05	0.000271	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—C3—type 2 diabetes mellitus	1.69e-05	0.00027	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMGCR—type 2 diabetes mellitus	1.68e-05	0.000268	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.67e-05	0.000268	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ADRA2A—type 2 diabetes mellitus	1.64e-05	0.000263	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.63e-05	0.000261	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.63e-05	0.00026	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.63e-05	0.00026	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.6e-05	0.000256	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.58e-05	0.000253	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2E1—type 2 diabetes mellitus	1.58e-05	0.000252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.57e-05	0.000252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.57e-05	0.000252	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1A2—type 2 diabetes mellitus	1.56e-05	0.000249	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC2A1—type 2 diabetes mellitus	1.56e-05	0.000249	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.55e-05	0.000248	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.54e-05	0.000247	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.54e-05	0.000247	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.52e-05	0.000244	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP3A4—type 2 diabetes mellitus	1.52e-05	0.000243	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SRC—type 2 diabetes mellitus	1.52e-05	0.000242	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCG—type 2 diabetes mellitus	1.49e-05	0.000239	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC2A4—type 2 diabetes mellitus	1.49e-05	0.000239	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.48e-05	0.000237	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—type 2 diabetes mellitus	1.48e-05	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.43e-05	0.000229	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.43e-05	0.000228	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.41e-05	0.000225	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.41e-05	0.000225	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.39e-05	0.000222	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.38e-05	0.000221	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—type 2 diabetes mellitus	1.35e-05	0.000217	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.32e-05	0.000211	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.3e-05	0.000207	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.29e-05	0.000207	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GNB3—type 2 diabetes mellitus	1.29e-05	0.000206	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.29e-05	0.000206	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—type 2 diabetes mellitus	1.28e-05	0.000205	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAT—type 2 diabetes mellitus	1.27e-05	0.000202	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOB—type 2 diabetes mellitus	1.23e-05	0.000197	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.23e-05	0.000196	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.21e-05	0.000194	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.2e-05	0.000192	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.2e-05	0.000192	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—type 2 diabetes mellitus	1.19e-05	0.000191	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.19e-05	0.000191	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.19e-05	0.00019	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000188	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LPL—type 2 diabetes mellitus	1.17e-05	0.000188	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.16e-05	0.000185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.15e-05	0.000185	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ADCY5—type 2 diabetes mellitus	1.15e-05	0.000184	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX1—type 2 diabetes mellitus	1.14e-05	0.000183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.14e-05	0.000182	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CD36—type 2 diabetes mellitus	1.11e-05	0.000178	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LPL—type 2 diabetes mellitus	1.11e-05	0.000177	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPP2CA—type 2 diabetes mellitus	1.1e-05	0.000176	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.08e-05	0.000173	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—type 2 diabetes mellitus	1.06e-05	0.000169	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.04e-05	0.000166	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARA—type 2 diabetes mellitus	1.04e-05	0.000166	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.02e-05	0.000163	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AGT—type 2 diabetes mellitus	1e-05	0.000161	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—C3—type 2 diabetes mellitus	9.96e-06	0.000159	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CALM1—type 2 diabetes mellitus	9.87e-06	0.000158	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOE—type 2 diabetes mellitus	9.83e-06	0.000157	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOA1—type 2 diabetes mellitus	9.72e-06	0.000156	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.5e-06	0.000152	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.47e-06	0.000152	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGT—type 2 diabetes mellitus	9.46e-06	0.000151	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—type 2 diabetes mellitus	9.42e-06	0.000151	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.3e-06	0.000149	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOE—type 2 diabetes mellitus	9.27e-06	0.000148	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—type 2 diabetes mellitus	9.27e-06	0.000148	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.16e-06	0.000147	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.74e-06	0.00014	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—type 2 diabetes mellitus	8.56e-06	0.000137	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—INS—type 2 diabetes mellitus	8.4e-06	0.000134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.27e-06	0.000132	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INS—type 2 diabetes mellitus	7.92e-06	0.000127	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.79e-06	0.000125	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—type 2 diabetes mellitus	7.7e-06	0.000123	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.66e-06	0.000123	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.65e-06	0.000122	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.62e-06	0.000122	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3R1—type 2 diabetes mellitus	7.37e-06	0.000118	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—type 2 diabetes mellitus	7.37e-06	0.000118	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.27e-06	0.000116	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.94e-06	0.000111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.94e-06	0.000111	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—type 2 diabetes mellitus	6.74e-06	0.000108	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RELA—type 2 diabetes mellitus	6.54e-06	0.000105	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.95e-06	9.52e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.9e-06	9.43e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.86e-06	9.37e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.57e-06	8.92e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.51e-06	8.82e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.4e-06	8.65e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.14e-06	8.22e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5e-06	8.01e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.59e-06	7.35e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.5e-06	7.2e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.46e-06	5.54e-05	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	3.39e-06	5.42e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.19e-06	5.11e-05	CbGpPWpGaD
